Elecsys HSV-2 IgG (08948887160)— 510(k) K220924

Name: FDA 510(k) clearance K220924
Creator: U.S. Food and Drug Administration
Published: 2022-10-12

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K220924 for Elecsys HSV-2 IgG (08948887160), Substantially Equivalent on 2022-10-12. Applicant: Roche Diagnostics. Device class: 2.

Clearance details

Applicant: Roche Diagnostics
Product code: Code MYF
Device class: Class 2
Regulation: 21 CFR 866.3305
Advisory panel: Microbiology
Date received: 2022-03-31
Decision date: 2022-10-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MYF

view all

K243575 — ARCHITECT HSV-2 IgG, ARCHITECT HSV-2 IgG Calibrator, ARCHITECT HSV-2 IgG Controls2025-02-12
K181514 — SeraQuest HSV Type 2 Specific IgG2019-06-13
K181334 — ADVIA Centaur Herpes-2 IgG2018-08-23
K152353 — SeraQuest HSV Type 2 Specific IgG2016-05-13
K103603 — ZEUS ELISA HSV GG-2 IGG TEST SYSTEM2011-05-20

More clearances from Roche Diagnostics

view all

K261686 — Elecsys Phospho-Tau (217P) Plasma2026-08-19
K252323 — cobas pulse blood glucose monitoring system2026-06-12
K252280 — Elecsys Anti-SARS-CoV-2 S2026-04-13
K260046 — Elecsys Anti-HBc II2026-04-07
K260048 — Elecsys Anti-HAV IgM2026-04-07

Adverse events under product code MYF

product code MYF

Injury: 316
Other: 1
Total: 317

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.